Dr. Kulkarni is the San Francisco based west region leader of QuintilesIMS Consulting Services. He has extensive experience in drug and diagnostics discovery and development, portfolio management, mergers and acquisitions, and commercialization processes. His clients include leading global biopharmaceutical companies. He is also Director of the QuintilesIMS Stem Cell Center in San Diego.
Prior to Quintiles, Avi was a Partner at Booz & Co., where he was the leader of the life sciences R&D business. He has been at the forefront of the transformation of the world’s leading Rx and Dx companies as they develop precision or personalized medicine capabilities and diversify into new businesses and markets.
Avi has deep roots in the biotechnology start-up community. He was a member of Sand Hill Angels till 2011. He has raised over $100MM for his start-up companies. He was CEO of Lumen Therapeutics (CV drugs), COO of Aviir (diagnostic tests for cardiovascular disease and insulin resistance) and CFO and head of Business Development of CareDx (XDx - AlloMap Cardiac gene expression testing).